Advertisement
Canada markets close in 5 hours 11 minutes
  • S&P/TSX

    21,983.63
    +111.67 (+0.51%)
     
  • S&P 500

    5,061.76
    +51.16 (+1.02%)
     
  • DOW

    38,470.91
    +230.93 (+0.60%)
     
  • CAD/USD

    0.7321
    +0.0020 (+0.28%)
     
  • CRUDE OIL

    82.22
    +0.32 (+0.39%)
     
  • Bitcoin CAD

    91,181.50
    +601.34 (+0.66%)
     
  • CMC Crypto 200

    1,441.75
    +26.99 (+1.91%)
     
  • GOLD FUTURES

    2,333.60
    -12.80 (-0.55%)
     
  • RUSSELL 2000

    2,003.01
    +35.53 (+1.81%)
     
  • 10-Yr Bond

    4.5820
    -0.0410 (-0.89%)
     
  • NASDAQ

    15,659.30
    +208.00 (+1.35%)
     
  • VOLATILITY

    16.32
    -0.62 (-3.66%)
     
  • FTSE

    8,037.87
    +14.00 (+0.17%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6835
    -0.0015 (-0.22%)
     

Company News for May 17, 2021

  • Shares of Aurora Cannabis Inc. ACB fell 6.3% after the company reported fiscal third-quarter 2021 adjusted loss per share of $0.24, wider than the Zacks Consensus Estimate of a loss of $0.17.

  • New Relic, Inc.’s NEWR shares gained 4.7% after the company delivered fiscal fourth-quarter 2021 adjusted loss per share of $0.27, narrower the Zacks Consensus Estimate of a loss of $0.46.

  • BioLife Solutions, Inc.’s BLFS shares gained 0.7% after the company reported first-quarter 2021 adjusted loss per share of $0.03, narrower than the Zacks Consensus Estimate of a loss of $0.05.

  • Shares of Globant S.A. GLOB advanced 5.1% after the company delivered first-quarter 2021 adjusted earnings per share of $0.83, beating the Zacks Consensus Estimate of $0.81.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BioLife Solutions, Inc. (BLFS) : Free Stock Analysis Report
 
Globant S.A. (GLOB) : Free Stock Analysis Report
 
New Relic, Inc. (NEWR) : Free Stock Analysis Report
 
Aurora Cannabis Inc. (ACB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research